These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1097 related items for PubMed ID: 23701943

  • 1. CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia.
    Dang H, Chen Y, Kamel-Reid S, Brandwein J, Chang H.
    Hum Pathol; 2013 Oct; 44(10):2038-46. PubMed ID: 23701943
    [Abstract] [Full Text] [Related]

  • 2. Prognostic factors in normal karyotype acute myeloid leukemia in the absence of the FLT3-ITD mutation.
    Jiang A, Jiang H, Brandwein J, Kamel-Reid S, Chang H.
    Leuk Res; 2011 Apr; 35(4):492-8. PubMed ID: 20684989
    [Abstract] [Full Text] [Related]

  • 3. Expression of CD4 is correlated with an unfavorable prognosis in wild-type NPM1, FLT3-ITD-negative cytogenetically normal adult acute myeloid leukemia.
    Guo RJ, Atenafu EG, Schimmer AD, Minden MD, Chang H.
    Int J Lab Hematol; 2017 Aug; 39(4):429-437. PubMed ID: 28318150
    [Abstract] [Full Text] [Related]

  • 4. CD34 expression on bone marrow blasts is a novel predictor of poor prognosis independent of FlT3-ITD in acute myeloid leukemia with the NPM1-mutation.
    Zhu HH, Liu YR, Jiang H, Lu J, Qin YZ, Jiang Q, Bao L, Ruan GR, Jiang B, Huang X.
    Leuk Res; 2013 Jun; 37(6):624-30. PubMed ID: 23473998
    [Abstract] [Full Text] [Related]

  • 5. Influence of FLT3-internal tandem duplication allele burden and white blood cell count on the outcome in patients with intermediate-risk karyotype acute myeloid leukemia.
    How J, Sykes J, Gupta V, Yee KW, Schimmer AD, Schuh AC, Minden MD, Kamel-Reid S, Brandwein JM.
    Cancer; 2012 Dec 15; 118(24):6110-7. PubMed ID: 22736495
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of immunophenotyping and gene mutations in elderly patients with acute myeloid leukemia with normal karyotype.
    Dang H, Jiang A, Kamel-Reid S, Brandwein J, Chang H.
    Hum Pathol; 2013 Jan 15; 44(1):55-61. PubMed ID: 22939316
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Distinctive expression of myelomonocytic markers and down-regulation of CD34 in acute myelogenous leukaemia with FLT3 tandem duplication and nucleophosmin mutation.
    Mori Y, Yoshimoto G, Kumano T, Miyamoto T, Iino T, Takenaka K, Iwasaki H, Harada N, Kinukawa N, Nagafuji K, Teshima T, Shimoda K, Akashi K, Harada M.
    Eur J Haematol; 2007 Jul 15; 79(1):17-24. PubMed ID: 17598835
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [A study of NPM1 and FLT3 gene mutations in acute myeloid leukemia].
    Wu DP, Yan LZ, Yang L, Chen SN, Wu XJ, Liang JY.
    Zhonghua Nei Ke Za Zhi; 2007 Nov 15; 46(11):907-10. PubMed ID: 18261272
    [Abstract] [Full Text] [Related]

  • 11. Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia.
    Shamaa S, Laimon N, Aladle DA, Azmy E, Elghannam DM, Salem DA, Taalab MM.
    Hematology; 2014 Jan 15; 19(1):22-30. PubMed ID: 23540998
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical impact of nucleophosmin mutations and Flt3 internal tandem duplications in patients older than 60 yr with acute myeloid leukaemia.
    Scholl S, Theuer C, Scheble V, Kunert C, Heller A, Mügge LO, Fricke HJ, Höffken K, Wedding U.
    Eur J Haematol; 2008 Mar 15; 80(3):208-15. PubMed ID: 18081718
    [Abstract] [Full Text] [Related]

  • 14. Prognostic impact of FLT3-ITD load in NPM1 mutated acute myeloid leukemia.
    Schnittger S, Bacher U, Kern W, Alpermann T, Haferlach C, Haferlach T.
    Leukemia; 2011 Aug 15; 25(8):1297-304. PubMed ID: 21537333
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Association of cup-like nuclei in blasts with FLT3 and NPM1 mutations in acute myeloid leukemia.
    Park BG, Chi HS, Jang S, Park CJ, Kim DY, Lee JH, Lee JH, Lee KH.
    Ann Hematol; 2013 Apr 15; 92(4):451-7. PubMed ID: 23238897
    [Abstract] [Full Text] [Related]

  • 17. Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML).
    Schneider F, Hoster E, Schneider S, Dufour A, Benthaus T, Kakadia PM, Bohlander SK, Braess J, Heinecke A, Sauerland MC, Berdel WE, Buechner T, Woermann BJ, Feuring-Buske M, Buske C, Creutzig U, Thiede C, Zwaan MC, van den Heuvel-Eibrink MM, Reinhardt D, Hiddemann W, Spiekermann K.
    Ann Hematol; 2012 Jan 15; 91(1):9-18. PubMed ID: 21744003
    [Abstract] [Full Text] [Related]

  • 18. Role of autologous hematopoietic stem cell transplantation according to the NPM1/FLT3-ITD molecular status for cytogenetically normal AML patients: a GOELAMS study.
    Guièze R, Cornillet-Lefebvre P, Lioure B, Blanchet O, Pigneux A, Recher C, Bonmati C, Fegueux N, Bulabois CE, Bouscary D, Vey N, Delain M, Turlure P, Himberlin C, Harousseau JL, Dreyfus F, Béné MC, Ifrah N, Chevallier P, GOELAMS.
    Am J Hematol; 2012 Dec 15; 87(12):1052-6. PubMed ID: 22911473
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Aberrant expression of CD7 in myeloblasts is highly associated with de novo acute myeloid leukemias with FLT3/ITD mutation.
    Rausei-Mills V, Chang KL, Gaal KK, Weiss LM, Huang Q.
    Am J Clin Pathol; 2008 Apr 15; 129(4):624-9. PubMed ID: 18343790
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.